NASDAQ:BYSI BeyondSpring (BYSI) Stock Price, News & Analysis $1.97 -0.03 (-1.50%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$1.86▼$2.2050-Day Range$1.77▼$2.4752-Week Range$0.65▼$4.00Volume32,821 shsAverage Volume108,134 shsMarket Capitalization$76.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get BeyondSpring alerts: Email Address Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About BeyondSpring Stock (NASDAQ:BYSI)BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy or radiation, including; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.Read More BYSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BYSI Stock News HeadlinesSeptember 3, 2024 | globenewswire.comBeyondSpring Announces Oral Presentation at the 2024 World Conference on Lung Cancer and Two Poster Presentations During ESMO Congress 2024 Showcasing its Lead Anti-Cancer Asset, PlinabulinAugust 6, 2024 | globenewswire.comSEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology IndicationsSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.May 22, 2024 | finance.yahoo.comBeyondSpring (NASDAQ:BYSI) shareholders have earned a 141% return over the last yearMay 16, 2024 | globenewswire.comBeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsMay 3, 2024 | globenewswire.comBeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsApril 30, 2024 | msn.comBeyondSpring GAAP EPS of -$0.54, revenue of $1.75MApril 29, 2024 | globenewswire.comBeyondSpring Provides Business Update and Reports Year End 2023 Financial ResultsSeptember 7, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.April 29, 2024 | globenewswire.comBeyondSpring Files 2023 Annual Report on Form 20-FMarch 25, 2024 | globenewswire.comBeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung CancerMarch 14, 2024 | finance.yahoo.comBYSI Oct 2024 7.500 callMarch 7, 2024 | finance.yahoo.comBYSI Mar 2024 7.500 callMarch 6, 2024 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.04%March 6, 2024 | finance.yahoo.comRetail investors invested in BeyondSpring Inc. (NASDAQ:BYSI) up 125% last week, insiders too were rewardedMarch 5, 2024 | finance.yahoo.comBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing RequirementsFebruary 22, 2024 | uk.finance.yahoo.comBeyondSpring Inc. (BYSI) stock historical prices & data – Yahoo FinanceJanuary 18, 2024 | morningstar.comBeyondSpring Inc BYSISee More Headlines Receive BYSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/29/2021Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BYSI CUSIPN/A CIK1677940 Webwww.beyondspringpharma.com Phone(646) 305-6387Fax1-646-882-4228Employees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.31 Quick Ratio2.31 Sales & Book Value Annual Sales$1.88 million Price / Sales40.98 Cash FlowN/A Price / Cash FlowN/A Book Value($0.91) per share Price / Book-2.16Miscellaneous Outstanding Shares39,029,000Free Float27,590,000Market Cap$76.89 million OptionableOptionable Beta0.26 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Lan Huang Ph.D. (Age 53)Co-Founder, Chairman & CEO Dr. June Lu Ph.D.Chief Scientific OfficerMr. Linqing JiaCo-FounderStephen KilmerHead of Investor RelationsMr. Gregg RussoSenior Vice President of Human ResourcesKey CompetitorsMagenta TherapeuticsNASDAQ:MGTAMEI PharmaNASDAQ:MEIPAlimera SciencesNASDAQ:ALIMAdaptimmune TherapeuticsNASDAQ:ADAPAkebia TherapeuticsNASDAQ:AKBAView All CompetitorsInstitutional OwnershipRenaissance Technologies LLCBought 12,500 shares on 8/9/2024Ownership: 0.032%Acadian Asset Management LLCSold 8,202 shares on 8/6/2024Ownership: 0.037%View All Institutional Transactions BYSI Stock Analysis - Frequently Asked Questions How have BYSI shares performed this year? BeyondSpring's stock was trading at $0.90 at the beginning of the year. Since then, BYSI shares have increased by 118.9% and is now trading at $1.97. View the best growth stocks for 2024 here. How were BeyondSpring's earnings last quarter? BeyondSpring Inc. (NASDAQ:BYSI) posted its quarterly earnings results on Wednesday, December, 29th. The company reported ($0.47) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.11. The company had revenue of $0.34 million for the quarter, compared to analyst estimates of $0.34 million. When did BeyondSpring IPO? BeyondSpring (BYSI) raised $4 million in an initial public offering (IPO) on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO. Who are BeyondSpring's major shareholders? BeyondSpring's top institutional shareholders include Acadian Asset Management LLC (0.04%) and Renaissance Technologies LLC (0.03%). How do I buy shares of BeyondSpring? Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BeyondSpring own? Based on aggregate information from My MarketBeat watchlists, some other companies that BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ) and Pfizer (PFE). This page (NASDAQ:BYSI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.